• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    大劑量吉西他濱膀胱灌注化療對膀胱非肌層浸潤性尿路上皮癌復發(fā)率的影響

    2021-08-31 06:06:09張卓張文圣萬濱盧依剛李勛鋼
    中國現(xiàn)代醫(yī)生 2021年20期
    關(guān)鍵詞:吉西浸潤性尿路

    張卓  張文圣  萬濱  盧依剛  李勛鋼

    [關(guān)鍵詞] 大劑量;吉西他濱;膀胱灌注;膀胱非肌層浸潤性尿路上皮癌;復發(fā)

    [中圖分類號] R737.1? ? ? ? ? [文獻標識碼] B? ? ? ? ? [文章編號] 1673-9701(2021)20-0062-04

    lation chemotherapy on recurrence rate of non-muscle invasive bladder urothelium carcinoma

    ZHANG Zhuo? ?ZHANG Wensheng? ?WAN Bin? ?LU Yigang? ?LI Xungang

    Department Ⅰ of Urology Surgery, Jiujiang No.1 People′s Hospital in Jiangxi Province, Jiujiang? ?332000, China

    [Abstract] Objective To explore the clinical efficacy of high-dose gemcitabine intravesical instillation chemotherapy on non-muscle invasive bladder urothelium carcinoma and its impacts on tumor recurrence. Methods A total of 60 patients with non-muscle invasive bladder urothelium carcinoma admitted to our hospital from September 2018 to September 2019 were divided into the control group and the observation group according to the random number table method. The control group was treated with conventional dose of gemcitabine chemotherapy,while the observation group was treated with high dose of gemcitabine intravesical instillation chemotherapy. The therapeutic efficacies, tumor markers,tumor recurrence time, tumor progression time, recurrence and complications of the two groups were compared. Results The objective remission rate of the observation group was 53.33%, which was higher than 30.00% of the control group, with statistically significant difference(P<0.05). After treatment, NSE and CEA in the observation group were (1.33±0.11)ng/mL and (3.42±1.05)ng/mL respectively, which were both lower than those in the control group, with statistically significant differences(P<0.05). In the observation group, the 1-year tumor recurrence rate was 10.00%, the tumor recurrence time was (17.31±2.62) months and the tumor progression time was (19.87±2.96) months. While in the control group, the 1-year tumor recurrence rate was 36.67%, the tumor recurrence time was (11.42±1.33) months and the tumor progression time was (17.54±1.71)months, with statistically significant differences(P<0.05). There was no statistically significant differences in the incidence of dysuria, hematuria, frequent micturition and myelosuppression between two groups (P>0.05). Conclusion The application of high-dose gemcitabine intravesical instillation chemotherapy on non-muscle invasive bladder urothelium carcinoma can improve the objective remission rate, reduce serum tumor markers, decrease tumor recurrence and prolong tumor recurrence time and progression time, which is worthy of clinical promotion and application.

    猜你喜歡
    吉西浸潤性尿路
    要想不被“尿路”困擾 就要把它扼殺在搖籃里
    浸潤性乳腺癌超聲及造影表現(xiàn)與P63及Calponin的相關(guān)性
    非小細胞肺癌晚期患者應用吉西他濱治療的護理體會
    乳腺浸潤性微乳頭狀癌的研究進展
    癌癥進展(2016年8期)2016-08-22 11:22:06
    重組人血小板生成素預防吉西他濱化療相關(guān)血小板減少癥的臨床觀察
    癌癥進展(2016年10期)2016-03-20 13:15:48
    乳腺浸潤性導管癌組織β-catenin、cyclinD1、CDK4蛋白表達及臨床意義
    惡性腫瘤患者應用吉西他濱化療對凝血功能的影響
    清熱化瘀排石湯治療尿路結(jié)石32例
    FHIT和PCNA在膀胱尿路上皮癌中的表達及相關(guān)性
    E-Cadherin在乳腺浸潤性導管癌組織中的表達及臨床意義
    宝清县| 乌兰浩特市| 若尔盖县| 东明县| 上林县| 兴安县| 县级市| 东辽县| 新兴县| 松阳县| 台前县| 西城区| 个旧市| 洛隆县| 佛山市| 醴陵市| 揭阳市| 兴海县| 商河县| 于田县| 漳平市| 黔东| 新龙县| 博客| 喀什市| 旌德县| 汝州市| 罗甸县| 雷波县| 鄂州市| 奉贤区| 南江县| 澳门| 漯河市| 临清市| 土默特右旗| 陆良县| 繁峙县| 横山县| 江津市| 永川市|